<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0005171"><a href="http://purl.obolibrary.org/obo/MONDO_0005171">MONDO:0005171</a></h3>
<p><strong>Label:</strong> chronic myeloproliferative disorder</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0013794">MONDO:0013794</a> (thrombocythemia 3), <a href="http://purl.obolibrary.org/obo/MONDO_0005029">MONDO:0005029</a> (essential thrombocythemia), <a href="http://purl.obolibrary.org/obo/MONDO_0011173">MONDO:0011173</a> (thrombocythemia 2), <a href="http://purl.obolibrary.org/obo/MONDO_0009692">MONDO:0009692</a> (primary myelofibrosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019111">MONDO:0019111</a> (familial thrombocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0011996">MONDO:0011996</a> (chronic myelogenous leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0008554">MONDO:0008554</a> (thrombocythemia 1),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_614521">OMIM:614521</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254450">OMIM:254450</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187950">OMIM:187950</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3318">Orphanet:3318</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300331">OMIM:300331</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601977">OMIM:601977</a>, <a href="http://www.orpha.net/ORDO/Orphanet_824">Orphanet:824</a>, <a href="http://www.orpha.net/ORDO/Orphanet_71493">Orphanet:71493</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608232">OMIM:608232</a>, <a href="http://www.orpha.net/ORDO/Orphanet_521">Orphanet:521</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100495">HP:0100495</a> (Mastocytosis))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100494">HP:0100494</a> (Abnormal mast cell morphology))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100326">HP:0100326</a> (Immunologic hypersensitivity))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0031466">HP:0031466</a> (Impairment in personality functioning))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012531">HP:0012531</a> (Pain))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011843">HP:0011843</a> (Abnormality of skeletal physiology))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0003549">HP:0003549</a> (Abnormality of connective tissue))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002014">HP:0002014</a> (Diarrhea))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000716">HP:0000716</a> (Depressivity))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000708">HP:0000708</a> (Behavioral abnormality))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system))) 58.30%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0200151">HP:0200151</a> (Cutaneous mastocytosis))) 53.73%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005547">HP:0005547</a> (Myeloproliferative disorder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100845">HP:0100845</a> (Anaphylactic shock))) 53.73%</li>
</ul>
</body>
</html>
